<DOC>
	<DOCNO>NCT00635856</DOCNO>
	<brief_summary>A study ass activity Iressa patient 's prostate cancer recur , rise PSA level</brief_summary>
	<brief_title>Open Label Trial Assess Iressa Prostate Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Gefitinib</mesh_term>
	<criteria>Prostate cancer diagnosis evidence metastasis Age 18 old Prior chemotherapy recurrent prostate cancer Radiotherapy complete within 28 day start study Incomplete heal prior cancer major surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Iressa</keyword>
	<keyword>Gefitinib</keyword>
	<keyword>Prostate Cancer</keyword>
	<keyword>PSA</keyword>
</DOC>